Agilent/$A
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Agilent
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab consisting of consumables and services related to life science and applied tools, and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.
Ticker
$A
Sector
Primary listing
NYSE
Industry
Life Sciences Tools & Services
Headquarters
Employees
18,000
ISIN
US00846U1016
Website
Agilent Metrics
BasicAdvanced
$33B
28.45
$4.06
1.23
$0.97
0.86%
Price and volume
Market cap
$33B
Beta
1.23
52-week high
$153.84
52-week low
$96.43
Average daily volume
2.3M
Dividend rate
$0.97
Financial strength
Current ratio
2.091
Quick ratio
1.417
Long term debt to equity
54.58
Total debt to equity
60.039
Dividend payout ratio (TTM)
23.76%
Interest coverage (TTM)
13.27%
Profitability
EBITDA (TTM)
1,750
Gross margin (TTM)
53.35%
Net profit margin (TTM)
17.59%
Operating margin (TTM)
22.22%
Effective tax rate (TTM)
14.95%
Revenue per employee (TTM)
$370,000
Management effectiveness
Return on assets (TTM)
8.00%
Return on equity (TTM)
18.88%
Valuation
Price to earnings (TTM)
28.447
Price to revenue (TTM)
4.985
Price to book
5.35
Price to tangible book (TTM)
28.11
Price to free cash flow (TTM)
27.787
Free cash flow yield (TTM)
3.60%
Free cash flow per share (TTM)
415.73%
Dividend yield (TTM)
0.84%
Forward dividend yield
0.86%
Growth
Revenue change (TTM)
0.56%
Earnings per share change (TTM)
-3.75%
3-year revenue growth (CAGR)
0.51%
10-year revenue growth (CAGR)
5.07%
3-year earnings per share growth (CAGR)
-0.68%
10-year earnings per share growth (CAGR)
14.14%
3-year dividend per share growth (CAGR)
6.21%
10-year dividend per share growth (CAGR)
7.63%
What the Analysts think about Agilent
Analyst ratings (Buy, Hold, Sell) for Agilent stock.
Bulls say / Bears say
Agilent Technologies reported better-than-expected third-quarter earnings, with adjusted EPS of $1.32 surpassing the consensus estimate of $1.26, indicating strong financial performance. (benzinga.com)
The company has maintained dividend payments for 13 consecutive years, with a current dividend yield of 0.74% and a notable dividend growth of 10.22% over the last twelve months, appealing to income-focused investors. (investing.com)
Agilent's PD-L1 IHC 28-8 pharmDx kit received EU IVDR certification for two new companion diagnostic indications, expanding treatment eligibility for non-small cell lung cancer and melanoma patients, potentially increasing market share. (stocktitan.net)
Agilent revised its full-year outlook to reflect a slower market recovery, now expecting revenue between $6.42 billion and $6.5 billion, down from previous estimates, indicating potential growth challenges. (benzinga.com)
Analysts have maintained a 'Market Perform' rating for Agilent, noting that its growth outlook remains less positive compared to competitors, which could impact investor sentiment. (investing.com)
Operational challenges, including parts shortages and supply chain disruptions, have led to decreased revenue across several product lines, highlighting the need for improved supply chain resilience. (finance.yahoo.com)
Data summarised monthly by Lightyear AI. Last updated on 4 Jun 2025.
Agilent Financial Performance
Revenues and expenses
Agilent Earnings Performance
Company profitability
Agilent News
AllArticlesVideos
Life sciences firm Agilent beats quarterly estimates on instrument demand
Reuters·3 weeks ago
Agilent Announces the Enhanced 8850 Gas Chromatograph: Compact, Powerful, and Now Mass Spec-Connected for Superior Analytical Performance
Business Wire·3 weeks ago
Pascal Soriot and Judy Gawlik Brown Named to Agilent Board of Directors
Business Wire·4 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
Jul1
Agilent
Dividend·Ex-dividend
Jul23
Agilent
Dividend·Payment
$0.248Per share
FAQs
What’s the current market cap for Agilent stock?
Agilent (A) has a market cap of $33B as of June 20, 2025.
What is the P/E ratio for Agilent stock?
The price to earnings (P/E) ratio for Agilent (A) stock is 28.45 as of June 20, 2025.
Does Agilent stock pay dividends?
Yes, the Agilent (A) stock pays dividends to shareholders. As of June 20, 2025, the dividend rate is $0.968 and the yield is 0.86%. Agilent has a payout ratio of 23.76% on a trailing twelve-month basis.
When is the next Agilent dividend payment date?
The next Agilent (A) dividend payment is scheduled for July 23, 2025.
What is the beta indicator for Agilent?
Agilent (A) has a beta rating of 1.23. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.